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Cognitiveimpairmentrepresentsacommonmentalhealthproblemincommunity-dwellingandinstitutionalizedolderadults,and
the prevalence increases with age. Multidisciplinary teams are often asked to assess cognitive and functional impairment in this
population.TheCognitiveAssessmentofMinnesotawascreatedbyoccupationaltherapistsforthispurposeandisfrequentlyused,
but has not been extensively validated. This study examined the performance of the CAM and compared it to the MMSE with 113
outpatient clinic patients over the age of 60. Subgroups were established based on scores on a depression inventory to determine
if the presence of depressed mood altered the relationship between the measures. Both measures demonstrated good internal
consistency. The overall correlation between the two measures was high, statistically signiﬁcant and remained high regardless of
depression status. We oﬀer recommendations about the utility of each measure in screening cognitive functioning for older adults.
1.Introduction
Cognitive impairment represents a common mental health
problem in community dwelling and institutionalized older
adults, and the prevalence increases with age [1]. Several
measures have been developed to assess cognitive func-
tioning in this population with some measures having a
greater emphasis on memory and language functioning in
analog conditions and others focusing more on functional
adaptive skill use. Occupational therapists often work within
multi-disciplinary settings and are frequently asked to assess
the functional and cognitive status of their patients. The
Cognitive Assessment of Minnesota (CAM) [2]w a sc r e a t e d
for this purpose. The CAM is a standardized assessment of
cognitive functioning developed by occupational therapists.
The advantage of using a measure like the CAM is that it
covers a greater range of cognitive impairment compared
to most cognitive screens, making it potentially more useful
as a screening measure. In addition to providing a global
measure of cognition, the CAM also assesses practical skill
domains. For example, the CAM allows for assessments
of working memory and simple mathematical ability (e.g.,
can the person make change) that would allow for speciﬁc
recommendations (e.g., providing assistance to the aﬀected
person in managing ﬁnances). The CAM also allows for
hierarchical grading of cognitive skills, which may be useful
in monitoring change over time. Thus, the CAM may be a
promising measure to be used in geriatric settings. Although
theCAMisfrequentlyusedinternationallybyOTsinpractice
andintrainingsettings[3–5],thepsychometricpropertiesof
the CAM have not been extensively validated.
One of the most common screening measures for cog-
nitive impairment is the Mini-Mental State Exam (MMSE)
[6], a scale developed in neurology to be used as a screener
in a number of settings, including medicine, neurology, and
psychiatry. The MMSE has proven to be a useful tool because
its simplicity allows providers from any discipline to screen
for cognitive impairments.2 Journal of Aging Research
Depression and cognitive impairment are commonly co-
occurring disorders in late life. The National Comorbidity
Study Replication (NCS-R) reports lifetime prevalence rates
of major depression for community dwelling adults over the
age of 60 to be as high as 10.6% and prevalence rates for
dysthymia at 1.3% [7]. It is likely that this is a conservative
ﬁgure as older adults with depression often present with less
sadness and report experiencing more physical or cognitive
symptoms, and thus the depressive symptoms may go
unrecognized [8]. Depression can complicate diﬀerential
diagnosis as it can exacerbate or mimic symptoms of
cognitive impairment. Research has revealed depression is
linked to impaired cognition in the areas of short-term
memory[9],attention[10–12],informationprocessing[10],
recognition[9],andexecutivefunctioning[10,12].However,
Monsch et al. have suggested that skills such as psychomotor
speed that decline with aging may be responsible for more of
the variance in the decline in scores on cognitive measures,
rather than the depression itself [13]. Given that cognitive
screening measures have varying demands on diﬀerent types
of cognitive abilities and that older adults may diﬀer from
younger adults on the extent that depression aﬀects each
area of cognitive functioning, the validity of screening
measures for use among older adults with depression may
be reduced. However, despite the widespread use of cognitive
screening measures among individuals with depression, few
studies have compared the psychometric properties of these
instruments for use with older adults with depression. If
the presence of depression negatively impacts cognitive
assessment measures, one would expect to see impaired
scores across similar cognitive screening measures. However,
if the cognitive measures are diﬀerentially aﬀected, then
perhaps some other factor may be responsible for the
diﬀerent levels of agreement between those measures. For
example, it may be that individuals with depression show
variability in response over time due to the eﬀects of fatigue,
eﬀortful processing, a perception of task diﬃculty, and
so forth. Clinically, this would be important to take into
account before choosing a screening measure to use with
individuals with depression. The purposes of this study were
to (1) investigate the relationship between two measures of
cognitive status (the MMSE and the CAM), (2) examine
if depressive symptoms moderate the relationship between
these measures, and (3) examine group diﬀerences on areas
similarly measured in both screening instruments.
2.MaterialsandMethods
2.1. Participants and Setting. Participants included 113
adults (25 men and 88 women) over the age of 60
(M = 81.00, SD = 8.57, range 61–95), predominantly
European American, with 43.8% of the sample having an
education level of 12 or more years. Eligible participants
were those who completed an evaluation at the Geriatric
Assessment Center (GAC) which is aﬃliated with three
universitysystemsintheMidwest.TheGACisacollaborative
multi-disciplinary assessment team consisting of a nurse,
occupational therapist, pharmacist, geriatrician (physician),
psychologist, and a social worker. Typical reasons that
individuals would contact the GAC include: self-referral
for concern over memory loss or depression; concern for
partner’s worsening memory, depression/isolation, anxiety,
or overmedication; and functional capacity issues (e.g.,
adult child concern for the capacity for parent(s) to live
independently/manage ﬁnances/maintain driving, mobility
concerns).A comprehensive evaluation by this team includes
a 2-3 hour home visit and a 4-hour clinic visit.
Because some sections of the MMSE (e.g., following a
written command, writing a sentence, copying a design) and
the CAM (e.g., subsections requiring the examinee to look
at a ﬂash card and perform the arithmetic problem) are not
appropriate for participants with sensory impairment, they
would not be given to individuals who are visually impaired
or illiterate, and because a section might be refused by a
participant, some participants were dropped from the ﬁnal
analyses, resulting in a sample of 103 older adults (23 men
and 80 women).
2.2. Assessment Instruments and Administration Procedures.
Three measures were administered to each participant as
part of a standard comprehensive assessment: The Mini-
MentalStateExam(MMSE)[6],theCognitiveAssessmentof
Minnesota (CAM) [2], and the Geriatric depression Screen,
short form (GDS-SF) [14, 15].
The MMSE is a 19-item assessment of cognitive status
commonly used in psychiatric settings [16]. The MMSE
usually takes approximately 10–15 minutes to administer
and has a maximum score of 30. The examination includes
measures of orientation, recall and recent memory, abstract
thinking,attentionandcalculation,andobjectidentiﬁcation.
Research on this measure indicates good reliability with
interrater correlations of r = .82 and test-retest reliability
ranging from r = .89 to r = .98 [6, 17]. The MMSE has
beenextensivelyresearchedandvalidated.Validitystudieson
this measure vary depending on the population measured
and the cut score utilized. For the commonly used cut
score of ≤24, research using the MMSE and comparing
it to dementia status as a criterion indicates sensitivity
rates of <85% and speciﬁcity rates of <98% in community
samples when compared to dementia status as diagnosed
by trained neuropsychological examiners [18, 19], 89%
sensitivity rates with corresponding speciﬁcity rates of 81%
in general practice samples [20], pooled sensitivity and
speciﬁcity rates of 71% and 95.6% in hospitalized patients
[21], and 84.9% and 60.8% in memory clinics [22]. For this
study, a member of the multi-disciplinary team who was
trained in its administration and scoring administered the
MMSE in the home at intake (Day 1).
The CAM is a 29-item standardized assessment of
cognitive functioning developed primarily for use with
individuals with brain injury, but also has data on a nonaf-
fected sample. This assessment usually takes 35–45 minutes
to administer. The administration time takes substantially
longer than a typical screen to administer (approximately
45min compared to 10–15min), yet it is more manageable
in integrated settings than a complete neuropsychological
battery which could take a minimum of 6 hours to complete.
The CAM provides information on a range of cognitiveJournal of Aging Research 3
skills including: attention span (distractibility), orientation,
recent and remote memory, basic language (register, process,
and respond to information), mathematical and practical
(monetary) skills. It also assesses temporal awareness, visual
memory and sequencing, auditory memory and sequencing,
discrimination skills (object identiﬁcation and matching),
mental ﬂexibility, and safety and judgment. The maximum
total score that can be obtained is 80. Very little data exits
on the psychometric properties of the CAM outside from
what is found within the examiner’s manual. Rustad and
DeGroot indicate an interrater alpha of 0.90, adequate test-
retest reliability, and good concurrent validity for level of
impairment when compared against professional clinical
judgment by occupational therapists [23]. This measure was
administered on Day 2 in the clinic by an occupational
therapist and an occupational therapy student trained in
CAM administration and scoring.
The GDS-SF is a 15-item depression inventory speciﬁ-
cally designed for use with older adults [15]. High scores
indicate greater severity of depressive symptoms. This
depressioninventory hasa maximumscoreof15,withscores
higher than ﬁve considered to be indicative of depression.
Theitemsassessoverallmood,changesinenergyandactivity
level, and attitudes about the future. The GDS-SF, also called
the GDS-15, was found to be as good as the longer version
of the GDS for assessing depression among older adults
with dementia [24]. This measure was administered on Day
1 in the home setting by one member of a three to four
personteamtrainedinadministrationandscoring.Theteam
consisted of an occupational therapist, nurse, pharmacist, or
psychologist and students from one of those disciplines (i.e.,
1 - 2p r o f e s s i o n a l sa n d2s t u d e n t sp e rt e a m ) .
2.3. Analyses. Pearson Product Moment Correlations were
calculated for total scores of the two cognitive measures
(CAM and MMSE) to determine the overall level of agree-
ment of these screening measures for a group of older adults.
Subgroups were established based on the presence or
absence of depressive symptoms to determine whether the
presence of depressed mood, as measured by the GDS-
SF, diﬀerentially altered the relationship between the two
measures. t-tests were conducted comparing participants
with depressed mood to participants without depressed
mood using the scores on the GDS-SF. The nondepressive
symptom group (NON) consisted of those with GDS scores
of 0–4. The depressive symptom group (DEP) consisted
of GDS scores of 5–15. The Pearson Product Moment
correlation described above was computed for each group
and coeﬃcients were then compared using Fisher’s Z trans-
formation and examined for signiﬁcant group diﬀerences.
Sub analyses were conducted to examine areas similarly
measured in both screening instruments. The two cognitive
measures were examined for items that sampled the same
basic skills (i.e., recall and orientation) (refer to Table 1).
The strength of the relationship between these subscales
for both measures was examined using Pearson Correlation
Coeﬃcients and a Fisher’s Z was then conducted to analyze
for signiﬁcant diﬀerences. Then, the two groups identiﬁed
earlier as DEP and NON were compared for the association
Table 1: Speciﬁc items used for sub analyses.
MMSE CAM
Orientation Orientation
What is the date? What is today’s date, including
month, date, and year?
What is the month?
What is the year?
What day is it? Is it morning, afternoon, or
evening right now?
What season are we in? What season are we in now?
What state are we in? Where are you now?
What city?
What county?
What is the name of this place? What happened to bring you into
the hospital?
What ﬂoor are we on?
Recall Recall
A while ago I asked you about 3
items, do you recall what they
were?
Tell me the three words I told
you earlier?
Apple, penny, table Plant, clock, rug
of depressive symptomology through examinations of these
two groups on each of these subscales using the same
statistical procedures.
Additionally, a reliability coeﬃc i e n tw a sr u no ne a c h
of the two cognitive measures to provide an index of each
measure’s reliability in this population. A Cronbach’s alpha
was conducted on both the total scores of each measure and
on the orientation subsection to provide an index of internal
consistency. It was not possible to conduct a Cronbach’s
alpha on the recall subsection due to the fact that both
measures only have one score/subscore available for the
recall section. According to convention, α o f. 7 0o rh i g h e ri s
considered to be acceptable/good within the social sciences.
3. Results
A Cronbach’s alpha was calculated for total scores of the
cognitive measures and for the orientation subsection. The
MMSE was found to have good internal consistency α =
.79 for total score and .82 for orientation. The CAM also
performed well, yielding an α = .87 for the total score and
α = .76 for orientation.
Descriptive statistics for both measures are depicted
in Table 2. Pearson Product Moment Correlation was
calculated for total scores for 103 participants on the two
cognitive measures with r = .74, P<. 01, indicating a strong
correlation. The depressive symptom group (DEP) consisted
of 36 older adults (11 men and 25 women; Mage = 76.9,
SD = 9.6, and 52.2% with 12+ years of education). The
nondepressive symptom (NON) group consisted of 67 older
adults (12 men and 55 women, Mage = 83.1, SD = 6.7, and
45.6% with 12+ years of education). Analyses on the two
measuresamongeachsubgroup(i.e.,DEPandNON)yielded
an r = .72, P<. 01 for NON and r = .79, P<. 01 for DEP.4 Journal of Aging Research




Totala 103 22.5 5.9
DEPb 36 23.0 5.2
NONc 67 22.2 6.2
CAM
Totala 103 19.9 2.7
DEPb 36 20.4 2.3
NONc 67 19.6 2.8
Note.. aGDS scores for all participants. bGDS scores of 5–15 only. cGDS
scores of 0–4 only.








CAM versus MMSE .786 .01 .724d .01
Recall .462 .01 .462d .07
Orientation .801 .01 .802d .01
NONc
CAM versus MMSE .724 .01 .746d .01
Recall .755 .01 .732d .07
Orientation .583 .01 .570d .01
Note. aGDS scores of all participants. bGDS scores of 6–15 only. cGDS scores
of 0–4 only. dSigniﬁes the use of partial regression correlation coeﬃcient
where age is held constant.
A Fisher Z was then conducted, indicating no signiﬁcant
group diﬀerence (z = 0.67, P = .50). When comparing DEP
to NON groups, an independent samples t-test indicated
no signiﬁcant group diﬀerences on sex, t = 1.47, P = .145,
but did indicate a signiﬁcant group diﬀerence on age,
t = 3.62, P<. 001. Therefore, partial regression correlation
coeﬃcients, holding age constant, were calculated for each
subanalysis and are described below. Secondary analyses
indicated the eﬀects of depressed mood on the overall
relation yielded an r = .72, P<. 01 for NON and r = .79,
P<. 01 for DEP. A Fisher Z was then conducted, indicating
no signiﬁcant group diﬀerence (z = 0.67, P = .50).
3.1. Subanalyses. Analyses were conducted to examine the
agreement between the two cognitive measures on speciﬁc
subsections for orientation and recall (see Table 3). For
orientation, the correlation for all participants was r = .65,
P<. 01, following standard conventions, a correlation in
this range suggests that the two measures have a moderate
agreement on this subtest. When comparing DEP and
NON groups using partial correlation coeﬃcients (holding
age constant), a Fisher Z indicated no signiﬁcant group
diﬀerences, z =− 1.08, P = .28. For recall, the correlation for
all participants yielded an r = .67, P<. 01, suggesting that
the two measures have moderate agreement on this subtest,
as well. When comparing DEP and NON partial correlation
coeﬃcients (holding age constant), a Fisher Z indicated no
signiﬁcant group diﬀerences, z =− 1.42, P = .16.
4. Discussion
Cognitive impairment is a common problem in older adults
and has been linked to several negative outcomes including
poor treatment adherence [25–28] and increased disability,
suggestinganeedforearlyrecognitioninmedicalandmental
healthtreatment.Multi-disciplinaryteamsareoftenaskedto
provide more speciﬁc and detailed answers and recommen-
dations than can be obtained through brief cognitive screen-
ing measures. For example, functional recommendations are
often sought by rehabilitation professionals (can Ms. Smith
resume daily activities?), social security disabilities services
(e.g., can Mr. Jones perform work-related activities?), and by
families seeking help with planning (e.g., is my aging parent
able to manage his/her ﬁnances independently?). Cognitive
screening measures like the MMSE, though frequently used,
are primarily gross cognitive screening tools and may
have several limitations when utilized for purposes beyond
detecting global cognitive impairment (e.g., MMSE has poor
utility for use with post-stroke medical patients [29]).
The CAM is a promising measure for use in geriatric
populations because of the wide range of abilities assessed
and its utility with brain-injured populations. Previously
only one small study has examined the psychometric prop-
erties of the CAM using the MMSE as a comparison. Rustad
and colleagues found a moderate correlation (r = .44,
P = .05), however the sample size reported in this study
was small (n = 16), and additional examinations are needed
to determine whether this relationship will exist in other
samples [23]. This study examined the utility of the CAM
as a screening measure and examined its relationship to the
MMSE in a relatively large sample of older adults in an
outpatient clinic setting.
Both measures evidenced adequate/good reliability when
evaluated using a Cronbach’s alpha. When examining the
orientation subsection alone, reliability estimates remain
adequate/good.Theoverallrelationsuggestsgoodagreement
between the two measures of cognitive status on orientation.
The data suggest that when depressive symptoms are taken
into consideration, overall scores were not aﬀected; however
there was a tendency for depression to aﬀect cognitive
functions such as recall and orientation. For example people
in the DEP group scored lower on the recall subsection on
the MMSE than they did on the CAM. Interestingly they
DEP group scored higher on the orientation subsection on
the MMSE than they did on the CAM. These ﬁndings were
consistent across the NON group, as well. Higher scores on
recall on the CAM could be aﬀected by the diﬀerence of
the type of words used in recall, however both measures use
commonly found objects. Attention could clearly be aﬀected
by the fact that the CAM takes longer than the MMSE to
administer, and this could in part account for diﬀerencesJournal of Aging Research 5
in scores on orientation. Alternatively, the diﬀerences in
orientation may be an artifact of the sample, since there
is no evidence in the research literature to suggest that
diﬀerences in orientation should exist between cognitive
screens. Replications of this study using larger or more
diverse samples may elucidate these ﬁndings.
Unfortunately, neither measure has an alternate form
available for use with those individuals with visual impair-
ment or those with illiteracy. These same challenges exist
for the majority of cognitive screens and many neuropsy-
chological test instruments that are currently available
(i.e., many rely heavily on visual and verbal abilities; e.g.,
Boston Naming Test) constituting a problem for the ﬁeld
of neuropsychology as a whole. In a recent survey of
neuropsychologists in the USA and Canada, Rabin and
colleagues reported on the most common assessment used.
Of the 20 neuropsychological assessment instruments used,
80% require adequate visual skills [30]. The authors are not
aware of any published cognitive screening instruments that
have been designed speciﬁcally for individuals with visual
impairment or illiteracy.
While this study is the ﬁrst large sample study to examine
the CAM and the MMSE, the drawback to utilizing clinical
data collected from an assessment center is that we cannot
control for ethnic diversity and the clinicians may not have
always been able to administer the assessments on the days
planned. Patient cancellations and rescheduling of appoint-
ments may have led to a longer delay in administration
(e.g., one week in between administration of assessment
measures rather than one day). Since participants with
vision or reading disabilities were excluded from the study,
results may only generalize to healthy and literate older
adults. In addition, because the sample was predominantly
European-American, we cannot assume generalization to
more diverse samples. In addition, because these data are
cross-sectional, we cannot assume that the relationship
between the two measures will remain stable over time,
particularly in the presence of cognitive impairment. Future
research should include follow up data to assess whether
the utility of these measures changes over time and with
advanced impairment. In addition, in order to investigate
the prognostic utility of the CAM, longitudinal studies are
required to evaluate its ability to predict both mild cognitive
impairment and dementia as compared to assessment by a
trained neuropsychologist.
5. Conclusions
This study ﬁnds the two measures to have good reliability
and agreement in assessing cognitive impairment, but that
each measure has a distinct advantage. The MMSE oﬀers
a shorter administration time, which may be beneﬁcial in
primary care settings where time constraints preclude a
longer assessment for cognitive impairment but detailed
function recommendations may not be needed. Whereas the
direct clinical usefulness of some of the information from
speciﬁc tasks of the CAM test (i.e., the problem solving task
that involves completing multiple errands in a day—assesses
executive functions that include planning, organization, and
sequencing ability) along with the opportunity to obtain a
largersampleofbehaviorinalltasksassessed,aresomeofthe
strengths of the CAM. From an evidence-based perspective,
the decision to select an assessment tool should be tied to
the goal or purpose of the assessment [31]. If the purpose
is only to obtain a quick simple screen (obtain a brief
snapshot of the person’s cognition to evaluate for risk of
cognitive impairment or to establish a baseline), then a
clinician could choose to use the MMSE. If the purpose
is to make clinically useful recommendations (e.g., focus
on functional adaptive skill use), the longer assessment will
be more helpful. The CAM is useful for geriatric teams
where the goal is to obtain a more comprehensive measure
of cognitive impairment. Given that the CAM allows for
assessmentofmorepracticalaspectsofcognitiveimpairment
and oﬀers more extensive assessment information than the
MMSE, including hierarchical grading of cognitive skills, the
CAMmaybemoreidealforsettingssuchashomehealthcare
or rehabilitation settings where the goal would be to have
more information about practical skills and activities of daily
living. However, the longer duration of testing may increase
issues associated with fatigue during assessment. Thus,
examiners would need to incorporate breaks as necessary or
administer over sessions to minimize test fatigue.
Therefore, our ﬁnding that the two measures are so
closely related means that clinicians can adjust or tailor their
screening based on the information they need (goal driven
assessment). In addition, having strongly correlated measure
means that those who work mainly with the MMSE can look
at the CAM and have a good idea about the individual’s cog-
nitive capacity and those who work with the CAM can look
at the MMSE and have a good idea about the individual’s
cognitive capacity (i.e., aids in communication within the
scientiﬁccommunity).AsGerontologyisaninterdisciplinary
ﬁeld, it is often useful to have tools that would aid in
communication about a patient between disciplines.
In sum, the CAM appears to be a promising measure for
use with older adults with cognitive impairment and when
examinersareinterestedinfunctionalcapacityrecommenda-
tions. More research is necessary exploring the psychometric
properties of the CAM to explore its full utility with diverse
populations. In addition, studies comparing the CAM to
other measures of functional capacity may be warranted.
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